Xencor (XNCR)

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

的Xencor, Inc. Common Stock（XNCR）股票的价格今天是$12.00，自市场开启。该公司市值为$8.57亿，日交易量为股。前一交易日收盘价为 $12.00。

您准备好开始了吗？按照以下步骤操作，或阅读我们关于在Kraken上从10美元起购买Xencor股票的指南。